[Effect of extracellular matrix components on adhesion of bone marrow multipotent mesenchymal stromal cells to polytetrafluoroethylene]. 2015

A A Karpenko, and I A Rozanova, and O V Poveshchenko, and A P Lykov, and N A Bondarenko, and I I Kim, and Iu V Nikonorova, and N A Podkhvatilina, and D S Sergeevichev, and I V Popova, and V I Konenkov
Laboratory of Experimental Surgery and Morphology, Centre for Vascular and Hybrid Surgery, Novosibirsk Scientific Research Institute for Circulatory Pathology named after Academician E.N. Meshalkin under the RF Ministry of Public Health, Novosibirsk, Russia.

Search for new bioengineering materials for creation of small-diameter vascular grafts is currently a priority task. One of the promising trends of creating tissue engineering constructions is coating the internal layer of implants made of polytetrafluoroethylene (PTFE) with autologous mesenchymal multipotent stromal cells. In the study we assessed the ability of separate components of the extracellular matrix such as fibronectin, type I collagen and type IV collagen to influence adhesion, proliferation and morphology of mesenchymal multipotent stromal cells being cultured on PTFE. Bone marrow multipotent stromal cells taken from second-passage Wistar rats in the amount of 106 per 1 cm2 were applied onto PTFE. We used the following variants of preliminary treatment of the material prior to seeding: fibronectin with type I collagen, fibronectin with type IV collagen, fibronectin with a mixture of type I and IV collagens, as well as a control group without coating. After six weeks of cell growth on PTFE patches the samples were subjected to fixation in 10% formalin followed by haematoxylin-eosin stain and morphometric assessment of adhered cells by calculation using the software AxioVision (Carl Zeiss), assessing the number of cells, area of the cellular monolayer, dimensions and ratios of the area of separate cells and the area of cellular nuclei. The maximal area of the monolayer from mesenchymal multipotent stromal cells on the PTFE surface was revealed while culturing with a mixture of fibronectin and type I and IV collagens. Cell colonization density while treatment of the synthetic material with mixtures of fibronectin with type I collagen, type IV collagen and type I and IV collagens demonstrated the results exceeding the parameters of the control specimen 5-, 2.5- and 7-fold, respectively. Hence, extracellular matrix components considerably increase enhance adhesion of cells to PTFE, as well as improve formation of a monolayer from mesenchymal multipotent stromal cells.

UI MeSH Term Description Entries
D008297 Male Males
D011138 Polytetrafluoroethylene Homopolymer of tetrafluoroethylene. Nonflammable, tough, inert plastic tubing or sheeting; used to line vessels, insulate, protect or lubricate apparatus; also as filter, coating for surgical implants or as prosthetic material. Synonyms: Fluoroflex; Fluoroplast; Ftoroplast; Halon; Polyfene; PTFE; Tetron. FEP,Fluon,Politef,Polytef,TFE,Teflon,Expanded PTFE,Fluoroplast,GORE-TEX,Goretex,PTFE,Tarflen,GORE TEX,PTFE, Expanded
D001807 Blood Vessel Prosthesis Device constructed of either synthetic or biological material that is used for the repair of injured or diseased blood vessels. Vascular Prosthesis,Blood Vessel Prostheses,Tissue-Engineered Vascular Graft,Graft, Tissue-Engineered Vascular,Grafts, Tissue-Engineered Vascular,Prostheses, Blood Vessel,Prostheses, Vascular,Prosthesis, Blood Vessel,Prosthesis, Vascular,Tissue Engineered Vascular Graft,Tissue-Engineered Vascular Grafts,Vascular Graft, Tissue-Engineered,Vascular Grafts, Tissue-Engineered,Vascular Prostheses,Vessel Prostheses, Blood,Vessel Prosthesis, Blood
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005109 Extracellular Matrix A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere. Matrix, Extracellular,Extracellular Matrices,Matrices, Extracellular
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D059630 Mesenchymal Stem Cells Mesenchymal stem cells, also referred to as multipotent stromal cells or mesenchymal stromal cells are multipotent, non-hematopoietic adult stem cells that are present in multiple tissues, including BONE MARROW; ADIPOSE TISSUE; and WHARTON JELLY. Mesenchymal stem cells can differentiate into mesodermal lineages, such as adipocytic, osteocytic and chondrocytic. Adipose Tissue-Derived Mesenchymal Stem Cell,Adipose Tissue-Derived Mesenchymal Stromal Cell,Adipose-Derived Mesenchymal Stem Cell,Bone Marrow Mesenchymal Stem Cell,Mesenchymal Stromal Cell,Mesenchymal Stromal Cells,Multipotent Bone Marrow Stromal Cell,Multipotent Mesenchymal Stromal Cell,Adipose Tissue-Derived Mesenchymal Stem Cells,Adipose Tissue-Derived Mesenchymal Stromal Cells,Adipose-Derived Mesenchymal Stem Cells,Adipose-Derived Mesenchymal Stromal Cells,Bone Marrow Mesenchymal Stem Cells,Bone Marrow Stromal Cell,Bone Marrow Stromal Cells,Bone Marrow Stromal Cells, Multipotent,Bone Marrow Stromal Stem Cells,Mesenchymal Progenitor Cell,Mesenchymal Progenitor Cells,Mesenchymal Stem Cell,Mesenchymal Stem Cells, Adipose-Derived,Mesenchymal Stromal Cells, Multipotent,Multipotent Bone Marrow Stromal Cells,Multipotent Mesenchymal Stromal Cells,Stem Cells, Mesenchymal,Wharton Jelly Cells,Wharton's Jelly Cells,Adipose Derived Mesenchymal Stem Cell,Adipose Derived Mesenchymal Stem Cells,Adipose Derived Mesenchymal Stromal Cells,Adipose Tissue Derived Mesenchymal Stem Cell,Adipose Tissue Derived Mesenchymal Stem Cells,Adipose Tissue Derived Mesenchymal Stromal Cell,Adipose Tissue Derived Mesenchymal Stromal Cells,Mesenchymal Stem Cells, Adipose Derived,Progenitor Cell, Mesenchymal,Progenitor Cells, Mesenchymal,Stem Cell, Mesenchymal,Stromal Cell, Mesenchymal,Stromal Cells, Mesenchymal,Wharton's Jelly Cell,Whartons Jelly Cells
D023822 Tissue Engineering Generating tissue in vitro for clinical applications, such as replacing wounded tissues or impaired organs. The use of TISSUE SCAFFOLDING enables the generation of complex multi-layered tissues and tissue structures. Engineering, Tissue

Related Publications

A A Karpenko, and I A Rozanova, and O V Poveshchenko, and A P Lykov, and N A Bondarenko, and I I Kim, and Iu V Nikonorova, and N A Podkhvatilina, and D S Sergeevichev, and I V Popova, and V I Konenkov
February 2008, Journal of the neurological sciences,
A A Karpenko, and I A Rozanova, and O V Poveshchenko, and A P Lykov, and N A Bondarenko, and I I Kim, and Iu V Nikonorova, and N A Podkhvatilina, and D S Sergeevichev, and I V Popova, and V I Konenkov
January 2008, Izvestiia Akademii nauk. Seriia biologicheskaia,
A A Karpenko, and I A Rozanova, and O V Poveshchenko, and A P Lykov, and N A Bondarenko, and I I Kim, and Iu V Nikonorova, and N A Podkhvatilina, and D S Sergeevichev, and I V Popova, and V I Konenkov
February 2018, Current protocols in stem cell biology,
A A Karpenko, and I A Rozanova, and O V Poveshchenko, and A P Lykov, and N A Bondarenko, and I I Kim, and Iu V Nikonorova, and N A Podkhvatilina, and D S Sergeevichev, and I V Popova, and V I Konenkov
March 2011, The international journal of biochemistry & cell biology,
A A Karpenko, and I A Rozanova, and O V Poveshchenko, and A P Lykov, and N A Bondarenko, and I I Kim, and Iu V Nikonorova, and N A Podkhvatilina, and D S Sergeevichev, and I V Popova, and V I Konenkov
February 2021, Biochemistry. Biokhimiia,
A A Karpenko, and I A Rozanova, and O V Poveshchenko, and A P Lykov, and N A Bondarenko, and I I Kim, and Iu V Nikonorova, and N A Podkhvatilina, and D S Sergeevichev, and I V Popova, and V I Konenkov
January 1998, British journal of haematology,
A A Karpenko, and I A Rozanova, and O V Poveshchenko, and A P Lykov, and N A Bondarenko, and I I Kim, and Iu V Nikonorova, and N A Podkhvatilina, and D S Sergeevichev, and I V Popova, and V I Konenkov
January 2020, Frontiers in cell and developmental biology,
A A Karpenko, and I A Rozanova, and O V Poveshchenko, and A P Lykov, and N A Bondarenko, and I I Kim, and Iu V Nikonorova, and N A Podkhvatilina, and D S Sergeevichev, and I V Popova, and V I Konenkov
February 2012, Bulletin of experimental biology and medicine,
A A Karpenko, and I A Rozanova, and O V Poveshchenko, and A P Lykov, and N A Bondarenko, and I I Kim, and Iu V Nikonorova, and N A Podkhvatilina, and D S Sergeevichev, and I V Popova, and V I Konenkov
November 2009, Biochemical and biophysical research communications,
A A Karpenko, and I A Rozanova, and O V Poveshchenko, and A P Lykov, and N A Bondarenko, and I I Kim, and Iu V Nikonorova, and N A Podkhvatilina, and D S Sergeevichev, and I V Popova, and V I Konenkov
May 2013, Bulletin of experimental biology and medicine,
Copied contents to your clipboard!